» Articles » PMID: 7044372

L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and Its Analogues As Inhibitors of Cysteine Proteinases Including Cathepsins B, H and L

Overview
Journal Biochem J
Specialty Biochemistry
Date 1982 Jan 1
PMID 7044372
Citations 249
Authors
Affiliations
Soon will be listed here.
Abstract

1. L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) at a concentration of 0.5 mM had no effect on the serine proteinases plasma kallikrein and leucocyte elastase or the metalloproteinases thermolysin and clostridial collagenase. In contrast, 10 muM-E-64 rapidly inactivated the cysteine proteinases cathepsins B, H and L and papain (t0.5 = 0.1-17.3s). The streptococcal cysteine proteinase reacted much more slowly, and there was no irreversible inactivation of clostripain. The cysteine-dependent exopeptidase dipeptidyl peptidase I was very slowly inactivated by E-64. 2. the active-site-directed nature of the interaction of cathepsin B and papain with E-64 was established by protection of the enzyme in the presence of the reversible competitive inhibitor leupeptin and by the stereospecificity for inhibition by the L as opposed to the D compound. 3. It was shown that the rapid stoichiometric reaction of the cysteine proteinases related to papain can be used to determine the operational molarity of solutions of the enzymes and thus to calibrate rate assays. 4. The apparent second-order rate constants for the inactivation of human cathepsins B and H and rat cathepsin L by a series of structural analogues of E-64 are reported, and compared with those for some other active-site-directed inhibitors of cysteine proteinases. 5. L-trans-Epoxysuccinyl-leucylamido(3-methyl)butane (Ep-475) was found to inhibit cathepsins B and L more rapidly than E-64. 6. Fumaryl-leucylamido(3-methyl)butane (Dc-11) was 100-fold less reactive than the corresponding epoxide, but was nevertheless about as effective as iodoacetate.

Citing Articles

Enteropathogenic E. coli effector Map interacts with Rab13 and regulates the depletion of the tight junction proteins occludin and claudins via cathepsin B-mediated mechanisms.

Mandal A, Walling P, Qureshi S, Kansal K, Aijaz S Biol Open. 2025; 14(2).

PMID: 39912222 PMC: 11892358. DOI: 10.1242/bio.061794.


Activation of VGLL4 Suppresses Cardiomyocyte Maturational Hypertrophic Growth.

Farley A, Gao Y, Sun Y, Zohrabian S, Pu W, Lin Z Cells. 2024; 13(16.

PMID: 39195232 PMC: 11352427. DOI: 10.3390/cells13161342.


Cathepsins L and B target HIF1α for oxygen-independent proteolytic cleavage.

Stuart S, Tarade D, Ohh M Sci Rep. 2024; 14(1):14799.

PMID: 38926538 PMC: 11208597. DOI: 10.1038/s41598-024-65537-9.


Nature-Inspired Gallinamides Are Potent Antischistosomal Agents: Inhibition of the Cathepsin B1 Protease Target and Binding Mode Analysis.

Spiwokova P, Horn M, Fanfrlik J, Jilkova A, Fajtova P, Leontovyc A ACS Infect Dis. 2024; 10(6):1935-1948.

PMID: 38757505 PMC: 11184554. DOI: 10.1021/acsinfecdis.3c00589.


Structural Elucidation and Antiviral Activity of Covalent Cathepsin L Inhibitors.

Falke S, Lieske J, Herrmann A, Loboda J, Karnicar K, Gunther S J Med Chem. 2024; 67(9):7048-7067.

PMID: 38630165 PMC: 11089505. DOI: 10.1021/acs.jmedchem.3c02351.


References
1.
Saklatvala J, Barrett A . Identification of proteinases in rheumatoid synovium. Detection of leukocyte elastase cathepsin G and another serine proteinase. Biochim Biophys Acta. 1980; 615(1):167-77. DOI: 10.1016/0005-2744(80)90020-0. View

2.
Takio K, Towatari T, Katunuma N, Titani K . Primary structure study of rat liver cathepsin B -- a striking resemblance to papain. Biochem Biophys Res Commun. 1980; 97(1):340-6. DOI: 10.1016/s0006-291x(80)80173-2. View

3.
Hashida S, Towatari T, Kominami E, Katunuma N . Inhibitions by E-64 derivatives of rat liver cathepsin B and cathepsin L in vitro and in vivo. J Biochem. 1980; 88(6):1805-11. DOI: 10.1093/oxfordjournals.jbchem.a133155. View

4.
Green G, Shaw E . Peptidyl diazomethyl ketones are specific inactivators of thiol proteinases. J Biol Chem. 1981; 256(4):1923-8. View

5.
Knight C . Human cathepsin B. Application of the substrate N-benzyloxycarbonyl-L-arginyl-L-arginine 2-naphthylamide to a study of the inhibition by leupeptin. Biochem J. 1980; 189(3):447-53. PMC: 1162023. DOI: 10.1042/bj1890447. View